Rethinking Mental Health & Neurology

Ranvier is transforming how we diagnose and treat depression, anxiety, Alzheimer’s, and Parkinson’s by using objective clinical measurement and advanced computational modelling.

TasteDX is the first taste-based screening test for depression. Combined with BioDX, our blood-based biomarker for neurodegenerative risk, we offer scalable tools to detect and monitor brain health with precision. From faster diagnosis to more personalised care, everything we build is designed to improve lives. Whether you are a patient looking for answers, a clinician seeking accuracy, or an investor shaping the future, Ranvier provides the tools to act early and with confidence..

Rethinking Mental Health & Neurology

Ranvier is transforming how we diagnose and treat depression, anxiety, Alzheimer’s, and Parkinson’s by using objective clinical measurement and advanced computational modelling.

TasteDX is the first taste-based screening test for depression. Combined with BioDX, our blood-based biomarker for neurodegenerative risk, we offer scalable tools to detect and monitor brain health with precision. From faster diagnosis to more personalised care, everything we build is designed to improve lives. Whether you are a patient looking for answers, a clinician seeking accuracy, or an investor shaping the future, Ranvier provides the tools to act early and with confidence..

Rethinking Mental Health & Neurology

Ranvier is transforming how we diagnose and treat depression, anxiety, Alzheimer’s, and Parkinson’s by using objective clinical measurement and advanced computational modelling.

TasteDX is the first taste-based screening test for depression. Combined with BioDX, our blood-based biomarker for neurodegenerative risk, we offer scalable tools to detect and monitor brain health with precision. From faster diagnosis to more personalised care, everything we build is designed to improve lives. Whether you are a patient looking for answers, a clinician seeking accuracy, or an investor shaping the future, Ranvier provides the tools to act early and with confidence..

Ranvier is Transforming Care

Ranvier is Transforming Care

1. We Detect Earlier

Taste, blood, and digital markers reveal signs of depression and neurodegeneration up to 15 years before symptoms.

2. We Track Treatment Response

Ranvier shows if treatment is working within days using real-time signals like changes in taste.

3. We Tailor Treatment

Agentic workflows combine taste, blood, and digital data to match each person to the right therapy.

A Global Emergency in Mental Health

A Global Emergency in Mental Health

Depression is the most misdiagnosed and undertreated health condition in the world. It affects over 300 million people and is often the first clinical sign of deeper neurological issues such as Alzheimer’s and Parkinson’s. Yet most diagnoses still rely on outdated questionnaires and subjective self-reporting. This gap leaves millions of people without answers or access to timely care. The world needs a new standard for speed, accuracy, and objectivity in mental health. Ranvier is building that standard.

50

50

yrs

yrs

Depression is the leading cause of death for men under 50.

The leading cause of death for men under 50.

50

50

%

%

Half of all postpartum depression cases go undiagnosed due to stigma and lack of screening.

Half of all postpartum depression cases go undiagnosed due to stigma and lack of screening.

35

35

yrs

yrs

Leading cause of death amongst all adults under 35 years old.

Leading cause of death amongst all adults under 35 years old.

3

3

X

X

Children in lower income brackets are three times more likely to develop major depressive disorder symptoms.

Children in lower income brackets are three times more likely to develop major depressive disorder symptoms.